Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Longevity Medical Institute® Opens Federally Licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory in Los Cabos

Transforming Health. Redefining Age. (PRNewsfoto/Longevity Medical Institute LLC)

News provided by

Longevity Medical Institute LLC

Mar 03, 2026, 12:12 ET

Share this article

Share toX

Share this article

Share toX

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 3, 2026 /PRNewswire/ -- Longevity Medical Institute® today announced the opening of its federally licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory, further expanding what is now one of the most comprehensive regenerative and advanced diagnostic medical campuses in Los Cabos.

Inside the Stem Cell Biotechnology Lab at Longevity Medical Institute®

Most clinics talk about stem cells. Very few can show you what’s happening behind the scenes.

This lab is the reason we can.

Our regenerative programs are supported by an on-site biotechnology operation under COFEPRIS federal oversight, created to bring real lab-level controls into the outpatient setting. It’s not just treatment, it’s traceability, documentation, and quality assurance built into the process.
Inside the Stem Cell Biotechnology Lab at Longevity Medical Institute® Most clinics talk about stem cells. Very few can show you what’s happening behind the scenes. This lab is the reason we can. Our regenerative programs are supported by an on-site biotechnology operation under COFEPRIS federal oversight, created to bring real lab-level controls into the outpatient setting. It’s not just treatment, it’s traceability, documentation, and quality assurance built into the process.
Welcome inside the Longevity Medical Institute Biotechnology Lab, the only biotechnology laboratory of its kind in all of Los Cabos.

In regenerative medicine, trust is not a slogan. Trust begins with safety, transparency, and measurable science.
Welcome inside the Longevity Medical Institute Biotechnology Lab, the only biotechnology laboratory of its kind in all of Los Cabos. In regenerative medicine, trust is not a slogan. Trust begins with safety, transparency, and measurable science.
Transparency You Can Verify
Unlike stem cell clinics that rely on vague claims, our lab process is built around documentation and verification. 

Every sample is validated with flow cytometry and advanced quality-control testing, and each batch is documented with a detailed report that includes:
• Cell type and origin
• Quantification and viability testing
• Purity and quality verification

Regenerative medicine involves living cellular material, and patients deserve certainty, not guesses.
Transparency You Can Verify Unlike stem cell clinics that rely on vague claims, our lab process is built around documentation and verification. Every sample is validated with flow cytometry and advanced quality-control testing, and each batch is documented with a detailed report that includes: • Cell type and origin • Quantification and viability testing • Purity and quality verification Regenerative medicine involves living cellular material, and patients deserve certainty, not guesses.

Operating under full federal COFEPRIS licensure, Mexico's national health regulatory authority, Longevity Medical Institute® is the only facility in Los Cabos holding federal authorization for stem cell administration and regenerative medicine services, including an ISO-certified biotechnology laboratory operating on-site.

The Institute integrates regenerative medicine, advanced imaging, cardiovascular assessment, surgical services, and comprehensive laboratory diagnostics within a single regulated clinical environment.

A Fully Integrated Medical Infrastructure

Longevity Medical Institute® operates:

  • A federally licensed on-site stem cell biotechnology laboratory
  • A fully integrated surgical center
  • An in-house clinical laboratory measuring more than 120 biomarkers
  • Advanced cardiovascular assessment programs
  • Full-body MRI utilizing DeepRecon AI reconstruction technology

All services are delivered by a unified team of 17 specialist physicians, scientists, and chemists working collaboratively within one clinical campus.

"Regenerative and preventive medicine require more than amenities. They require regulatory compliance, laboratory validation, and physician oversight," said Dr. Kirk Sanford, Founder and CEO of Longevity Medical Institute®. "We have built an infrastructure designed to prioritize safety standards, measurable diagnostics, and documented quality control."

Not a One-Size-Fits-All Approach

Longevity Medical Institute® emphasizes that regenerative medicine is not a one-size-fits-all discipline. Under physician supervision, the Institute supports multiple cellular options to align with individual clinical evaluations and objectives.

The Biotechnology Laboratory prepares and characterizes mesenchymal stromal cell materials derived from five distinct tissue sources used within physician-directed regenerative programs:

  • Placental tissue (P-MSCs)
  • Wharton's jelly (WJ-MSCs)
  • Adipose tissue (ad-MSCs)
  • Endometrial tissue (eMSCs)
  • Dental pulp (DP-MSCs)

In addition, the laboratory prepares exosome materials utilized within regenerative medicine protocols.

Each preparation undergoes structured quality-control testing prior to clinical use. Validation includes flow cytometry analysis to assess cell count, viability, and surface marker characterization. Documentation may include sterility screening, endotoxin testing, mycoplasma testing, cryopreservation protocol records, and full chain-of-custody traceability.

Every preparation must meet predefined internal release criteria before administration.

Advanced Imaging and Preventive Diagnostics

Longevity Medical Institute® also provides advanced diagnostic services designed to support comprehensive physician evaluation.

The Institute utilizes full-body MRI enhanced by DeepRecon AI technology, designed to optimize image reconstruction efficiency and clarity. These scans are performed under physician supervision for structural imaging review.

Cardiovascular assessment programs are tailored to individual risk profiles. The on-site clinical laboratory measures more than 120 biomarkers, allowing detailed laboratory analysis within the same facility.

All regenerative and diagnostic services are physician-directed medical procedures performed within a licensed medical setting. Individual findings and outcomes vary based on clinical circumstances.

Why Los Cabos

Los Cabos welcomes more than three million international visitors annually and is recognized as one of Mexico's most established luxury travel destinations. With direct flights from major U.S. and Canadian cities, internationally recognized hospitality infrastructure, and established healthcare oversight, the region offers accessibility combined with privacy and discretion.

Located along the Sea of Cortez where desert meets ocean, the region provides year-round sunshine and a stable coastal climate often sought by patients pursuing multi-day medical evaluation or regenerative programs.

Longevity Medical Institute® operates within the established hotel corridor of San José del Cabo, combining proximity to international resorts with the structure of a federally licensed medical facility.

Integrated Medical and Concierge Experience

Unlike hospitality-driven wellness resorts, Longevity Medical Institute® operates as a regulated medical institution with surgical, laboratory, and imaging infrastructure integrated within one clinical campus.

Patients traveling from outside the region may access coordinated concierge services, private transportation arrangements, and ocean-view villa accommodations designed to provide privacy and comfort during multi-day programs.

About Longevity Medical Institute®

Longevity Medical Institute® is a regenerative medicine and advanced diagnostics center based in Los Cabos, Mexico. The Institute operates under federal COFEPRIS licensure and provides physician-directed regenerative medicine services, advanced imaging, cardiovascular assessment, comprehensive biomarker testing, and surgical procedures within an integrated medical campus.

For more information, visit www.longevity-institute.com. 

SOURCE Longevity Medical Institute LLC

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Longevity Medical Institute™ Integrates OncoSeek® to Launch One of Mexico's Most Advanced Cancer Screening Programs

Longevity Medical Institute™ Integrates OncoSeek® to Launch One of Mexico's Most Advanced Cancer Screening Programs

Longevity Medical Institute™ (LMI), Mexico's premier center for regenerative medicine, anti-aging therapies, and advanced diagnostics, is proud to...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.